title: COX-2 inhibition attenuates endotoxin-induced downregulation of organic anion transporters in the rat renal cortex.
abstract: Renal excretion of organic anions such as para-aminohippurate is reduced during severe sepsis and following ischemia/reperfusion injury. In order to better define the pathophysiology of sepsis-associated renal tubular dysfunction we measured the effect of lipopolysaccharide on renocortical organic anion transporter (OAT) expression in the rat. Prostaglandin E2 (PGE2) downregulates OATs in vitro, therefore, we also evaluated the effect of the cyclooxygenase (COX)-2 inhibitor parecoxib on this process. Endotoxemia caused a time- and dose-dependent decrease of OAT1 and OAT3 expression that paralleled increased renocortical COX-2 expression and PGE2 formation. Pretreatment with parecoxib decreased endotoxin-stimulated PGE(2) formation. Parecoxib attenuated OAT1 and OAT3 gene repression in the rat kidney following endotoxin treatment and during ischemia/reperfusion-induced acute renal injury. COX-2 inhibition improved the creatinine clearance in lipopolysaccharide-treated rats but not after ischemia/reperfusion-induced acute renal injury. The decreased clearance of para-aminohippurate in rats following endotoxin- or ischemia/reperfusion-induced renal injury was improved by parecoxib. Our findings show that COX-2 derived prostanoids downregulate OATs during lipopolysaccharide-induced acute renal injury.
authors.affiliation: Institut für Physiologie, Universität Regensburg, Regensburg, Germany. klaus.hoecherl@chemie.uni-regensburg.de
authors.forename: Klaus
authors.initials: K
authors.lastname: Höcherl
authors.forename: Christoph
authors.initials: C
authors.lastname: Schmidt
authors.forename: Michael
authors.initials: M
authors.lastname: Bucher
mesh_terms: D000208:Acute Disease; D000818:Animals; D051546:Cyclooxygenase 2 / Q000502:physiology*; D052246:Cyclooxygenase 2 Inhibitors / Q000494:pharmacology*; D015232:Dinoprostone; D015536:Down-Regulation / Q000187:drug effects / Q000235:genetics; D007555:Isoxazoles / Q000494:pharmacology; D007672:Kidney Cortex / Q000378:metabolism*; D007674:Kidney Diseases / Q000139:chemically induced; D008070:Lipopolysaccharides / Q000494:pharmacology*; D008297:Male; D027362:Organic Anion Transport Protein 1 / Q000235:genetics; D027361:Organic Anion Transporters / Q000235:genetics*; D029362:Organic Anion Transporters, Sodium-Independent / Q000235:genetics; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D052246:Cyclooxygenase 2 Inhibitors; D007555:Isoxazoles; D008070:Lipopolysaccharides; D027362:Organic Anion Transport Protein 1; D027361:Organic Anion Transporters; D029362:Organic Anion Transporters, Sodium-Independent; C421043:Slc22a6 protein, rat; C114338:organic anion transport protein 3; C409945:parecoxib; D051546:Cyclooxygenase 2; C489691:Ptgs2 protein, rat; D015232:Dinoprostone